RaQualia Pharma Inc. (TYO:4579)
Japan · Delayed Price · Currency is JPY 473.00
-3.00 (-0.63%)
Jun 24, 2026, 11:30 AM JST
RaQualia Pharma Market Cap
RaQualia Pharma has a market cap or net worth of 12.39 billion as of June 23, 2026. Its market cap has decreased by -15.65% in one year.
Market Cap
12.39B
Enterprise Value
10.69B
Revenue
3.82B
Ranking
n/a
PE Ratio
221.18
Stock Price
473.00
Market Cap Chart
Since July 20, 2011, RaQualia Pharma's market cap has decreased from 19.90B to 12.39B, a decrease of -37.74%. That is a compound annual growth rate of -3.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 12.39B | -49.84% |
| Dec 30, 2025 | 24.70B | 194.57% |
| Dec 30, 2024 | 8.39B | -43.62% |
| Dec 29, 2023 | 14.87B | -42.44% |
| Dec 30, 2022 | 25.84B | 5.05% |
| Dec 30, 2021 | 24.60B | 17.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Japan Tissue Engineering | 24.93B |
| Renascience | 23.70B |
| AnGes | 19.06B |
| StemRIM | 19.06B |
| Stella Pharma | 11.77B |
| ReproCELL | 11.69B |
| CanBas | 10.88B |
| Immuno-Biological Laboratories | 9.33B |